A detailed history of Cubist Systematic Strategies, LLC transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 507,867 shares of SENS stock, worth $238,697. This represents 0.0% of its overall portfolio holdings.

Number of Shares
507,867
Previous 415,404 22.26%
Holding current value
$238,697
Previous $166,000 6.63%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.32 - $0.49 $29,588 - $45,306
92,463 Added 22.26%
507,867 $177,000
Q2 2024

Aug 14, 2024

BUY
$0.37 - $0.52 $31,635 - $44,460
85,501 Added 25.92%
415,404 $166,000
Q1 2024

May 15, 2024

BUY
$0.5 - $0.73 $993 - $1,450
1,987 Added 0.61%
329,903 $174,000
Q4 2023

Feb 14, 2024

BUY
$0.48 - $0.7 $56,076 - $81,777
116,825 Added 55.34%
327,916 $186,000
Q3 2023

Nov 14, 2023

SELL
$0.5 - $1.05 $575,486 - $1.21 Million
-1,150,972 Reduced 84.5%
211,091 $126,000
Q2 2023

Aug 14, 2023

BUY
$0.55 - $0.89 $749,134 - $1.21 Million
1,362,063 New
1,362,063 $1.04 Million
Q1 2022

May 16, 2022

SELL
$1.54 - $3.71 $31,371 - $75,576
-20,371 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$2.58 - $3.91 $3,250 - $4,926
-1,260 Reduced 5.82%
20,371 $54,000
Q3 2021

Nov 15, 2021

SELL
$2.77 - $4.05 $390,063 - $570,308
-140,817 Reduced 86.68%
21,631 $73,000
Q2 2021

Aug 16, 2021

BUY
$1.71 - $4.14 $188,182 - $455,598
110,048 Added 210.02%
162,448 $624,000
Q1 2021

May 17, 2021

BUY
$0.85 - $5.27 $44,540 - $276,148
52,400 New
52,400 $138,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $219M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.